Haemophilus influenzae

Lore & Background

Haemophilus influenzae is a small, Gram-negative bacterium, typically measuring between 0.3 and 1 micrometer. It is pleomorphic, often appearing as a coccobacillus or rod, and is non-motile despite possessing pili. These pili are specialized for strong adhesion to the human nasopharynx, resisting detachment during coughing or sneezing. The bacterium has a thin peptidoglycan layer and an outer membrane containing lipopolysaccharide; some strains also have a polysaccharide capsule. Its cell wall contains autotransporter proteins, such as Hap, which facilitate binding to mucus linings or non-ciliated epithelial cells and promote microcolony formation, contributing to biofilms in infections like those of the middle ear or lungs. The species is facultatively anaerobic, capnophilic, and mesophilic, growing best between 35 and 37 °C. It uses the Embden–Meyerhof–Parnas pathway for glycolysis and an anabolic pentose phosphate pathway, but its citric acid cycle is incomplete, lacking citrate synthase, aconitate hydratase, and isocitrate dehydrogenase. First described by Richard Pfeiffer in 1893 during an influenza pandemic, it was mistakenly identified as the cause of influenza. Encapsulated strains are classified into six serotypes (a through f), with type b (Hib) being most common in children and characterized by a polyribosyl ribitol phosphate capsule. Unencapsulated, nontypable strains are genetically diverse and often part of normal human flora in the respiratory tract, genitals, and conjunctivae. Penicillin-binding proteins in the cell wall are targets for beta-lactam antibiotics; resistance emerged in the 1970s via beta-lactamase production, shifting treatment from ampicillin to cephalosporins, though further resistance has arisen from mutations in penicillin-binding protein 3.

Reader's Guide

Haemophilus influenzae is significant as a major cause of invasive infections in infants and children, particularly meningitis, pneumonia, and bloodstream infections. Serotype b (Hib) was a leading cause of meningitis in young children, frequently causing deafness and mental degradation. The development of the Hib vaccine in the 1980s has almost eliminated this disease in developed countries. The bacterium also holds historical importance as the first free-living organism to have its entire genome sequenced, paving the way for modern genomics. Its genome sequencing demonstrated the whole-genome shotgun method and revealed that about 90% of its genes have homologs in E. coli. Antibiotic resistance is a concern, with many isolates resistant to penicillin, leading to changes in treatment from ampicillin to cephalosporins, though further resistance has emerged. The bacterium's ability to form biofilms and its specialized pili for adhesion contribute to its pathogenicity.

Did You Know?

• The Hib vaccine, developed in the 1980s, has almost eliminated Hib infections in developed countries.
• H. influenzae pili resist unwinding, allowing stronger adhesion to the human nasopharynx to resist expulsion when coughing or sneezing.

A Name Born of Mistake: The Pfeiffer Story

The story of Haemophilus influenzae begins with a dramatic misidentification. That error in judgment, however, proved to be the bacterium's permanent identity: the species was christened "influenzae" in direct reference to the disease it was wrongly blamed for causing. Pfeiffer's bacillus, as it was also known, carried that misleading name for decades before microbiologists finally untangled the true etiology of influenza. Despite the naming confusion, the organism itself is a well-defined member of the family Pasteurellaceae—a Gram-negative, non-motile, coccobacillary, facultatively anaerobic, and capnophilic pathogen. It thrives in the mesophilic range, with optimal growth between 35 and 37 degrees Celsius, conditions that mirror the human body's internal environment. What Pfeiffer stumbled upon in a moment of pandemic urgency turned out to be a far more complex and persistent human pathogen than the simple influenza agent he had imagined.

Hib and the Arms Race Against Resistance

Few bacterial pathogens have shaped public health policy as profoundly as Haemophilus influenzae, particularly its type b serotype, known as Hib. Before the 1980s, Hib was a leading cause of bacterial meningitis in infants and young children, and survivors frequently endured devastating sequelae including permanent deafness and significant cognitive impairment. The bacterium's arsenal extends well beyond the meninges; it is responsible for a broad spectrum of both localized and invasive infections in vulnerable populations, including pneumonia and bloodstream infections. Managing these infections has been an ongoing arms race. The organism is frequently resistant to the penicillin family, though amoxicillin combined with clavulanic acid remains an option for milder presentations. When beta-lactamase-producing strains emerged in the 1970s, clinical guidelines shifted from ampicillin to cephalosporins for severe cases. Yet resistance continued to evolve, with modifications in the transpeptidase domain of penicillin binding protein 3 conferring tolerance to cephalosporins as well. The development of an effective Hib vaccine in the 1980s, targeted specifically at the age group most at risk, has nearly eradicated Hib disease in developed nations, standing as one of the great triumphs of preventive medicine.

Engineering Adhesion: Pili, Autotransporters, and Biofilms

Despite its diminutive size—ranging from roughly 0.3 to 1 micrometer—Haemophilus influenzae is a master of surface attachment. Its cell envelope follows the classic Gram-negative architecture: a thin peptidoglycan sandwiched between the inner membrane and an outer membrane studded with lipopolysaccharide. Certain encapsulated strains wrap themselves in an additional polysaccharide shell that aids both protection and colonization. The bacterium is pleomorphic, shifting between coccobacillary and rod-like forms, yet it remains firmly non-motile. Its pili, however, are far from decorative. Unlike the pili of Escherichia coli, those of H. influenzae resist mechanical unwinding, granting them a tenacious grip on the human nasopharynx that withstands the force of coughing and sneezing. Non-typeable strains supplement pili with adhesins and specialized Hia and Hap proteins. The Hap autotransporters embedded in the cell wall latch onto as-yet-unidentified receptors on mucus linings and non-ciliated epithelial cells, simultaneously promoting the assembly of microcolonies. These microcolonies are believed to be the precursors of the biofilms that drive middle-ear and pulmonary infections, anchoring the bacterium firmly within its host.

First in the Queue: The 1995 Genome Milestone

The landmark effort was led by Craig Venter and his colleagues at the Institute for Genomic Research, an institution that would later become the J. Craig Venter Institute. The project's selection of this particular bacterium was no accident; Nobel laureate Hamilton Smith, one of the project's senior figures, had spent decades studying H. influenzae and was able to supply high-quality DNA libraries that made the work feasible. The team employed the then-novel whole-genome shotgun strategy, and the results were published in the journal Science. Remarkably, roughly ninety percent of these genes share homologs with Escherichia coli, another gamma-proteobacterium, with protein sequence similarity spanning a wide range from 18 to 98 percent. That single sequencing milestone opened the door to the modern era of genomics and redefined what was possible in microbial biology.